Alere (ALR) reported a loss of $0.28 per share in its fourth quarter. The company�s revenue for the quarter was $623.29 million, down 6.6% on a year-over-year basis. Revenue missed consensus forecast by $5.24 million.

Epizyme (EPZM) reported a loss of $0.49 per share in its second quarter. The company�s loss was 3 cents below consensus forecast. EPZM reported revenue of $0.47 million, down 36.5% on a year-over-year basis. Revenue missed consensus forecast by $0.41 million.

Allergan (AGN) reported earnings of $3.35 per share in its second quarter, beating consensus forecast by 3 cents. The company�s revenue for the quarter was $3.71 billion, up 1.1% on a year-over-year basis. Revenue missed consensus forecast by $270 million.

Horizon Pharma (HZNP) reported earnings of $0.62 per share in its second quarter, beating consensus forecast by 12 cents. The company reported revenue of $257.4 million, up 48.9% on a year-over-year basis. Revenue beat consensus forecast by $22.52 million.

Tonix Pharmaceuticals (TNXP) reported a loss of $0.50 per share in its second quarter, beating consensus forecast by 5 cents. The company ended the quarter with $31.2 million in cash and cash equivalents on its balance sheet.

Adaptimmune (ADAP) reported a loss of $0.31 per share in its second quarter. The company reported revenue of $0.33 million, down 88.1% on a year-over-year basis